BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.10
+0.10 (0.34%)
Apr 29, 2026, 1:19 PM CST
-12.35%
Market Cap 745.31M
Revenue (ttm) 262.66M
Net Income (ttm) 42.43M
Shares Out 25.61M
EPS (ttm) 1.65
PE Ratio 17.64
Forward PE n/a
Dividend 1.50 (5.17%)
Ex-Dividend Date Aug 7, 2025
Volume 30,641
Average Volume 11,790
Open 28.80
Previous Close 29.00
Day's Range 28.40 - 29.20
52-Week Range 28.05 - 35.80
Beta 0.19
RSI 43.81
Earnings Date Mar 27, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory mice and rats in Taiwan and internationally. It offers lab animals, such as rat, mice, and others, as well as surgical services; rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment; various reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin testing system, r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 91
Stock Exchange Taipei Exchange
Ticker Symbol 6662
Full Company Profile

Financial Performance

In 2025, BioLASCO Taiwan's revenue was 262.66 million, a decrease of -10.20% compared to the previous year's 292.50 million. Earnings were 42.43 million, a decrease of -3.63%.

Financial Statements

News

There is no news available yet.